Daniels Mark 4
4 · Twist Bioscience Corp · Filed Feb 26, 2021
Insider Transaction Report
Form 4
Daniels Mark
Chief Compliance Officer & GC
Transactions
- Exercise/Conversion
Common Stock
2021-02-24$23.33/sh+620$14,465→ 67,546 total - Sale
Common Stock
2021-02-24$134.31/sh−620$83,272→ 66,926 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-02-24−620→ 19,855 totalExercise: $23.33Exp: 2029-10-23→ Common Stock (620 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- [F2]25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.